• AstraZeneca paused its coronavirus vaccine trials
• US equities try to rebound from a US-led tech rout
European indices ended higher, erasing previous sessions losses as the tech sell-off in the US slowed down. Still, sentiment was hit by the possibility that AstraZeneca Covid-19 vaccine could be delayed after a person participating in one of the studies got sick. Stat News reported that the patient had a serious neurological symptom but he's improving and could be discharge from hospital today. Tomorrow markets’ attention will focus on the ECB monetary policy decision as investors will be looking for further hints on when more stimulus will be added through the pandemic emergency purchase programme. During today's session DAX 30 rose 2.1%, CAC 40 gained 1.6% and FTSE 100 finished 1.62% higher.
Gold prices rebounded to touch a near one-week high of $1,949 an ounce while silver price is approaching $27 resistance level, amid a slightly weaker dollar. WTI crude prices rose more than 4% to trade around $38.3 a barrel, while Brent crude futures gained more than 3.4% to trade around $41.10 a barrel, partially erasing some of the previous session’s heavy losses. Oil traders now await the API report which will be released in the evening.
NZDUSD - currency pair managed to bounce off the support zone at 0.66 which is additionally supported by 50 MA (green line) and rally. Should upbeat moods prevail, resistance at 0.6714 may come into play. On the other hand, breaking below the aforementioned support may trigger a bigger downward move towards 0.65 level. Source: xStation5This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
